Almost every week a new agent is added to the list of drugs associated with acquired long QT syn- drome (LQTS) and torsades de pointes (TdP). Despite this impressive number of reports, the awareness of this subject is still limited among medical professionals and it is virtually absent among the general public, even if some of the adverse reactions have been observed during treatment with agents marketed "over the counter."
Exploring the hidden danger of noncardiac drugs
PRIORI, SILVIA GIULIANA
1998-01-01
Abstract
Almost every week a new agent is added to the list of drugs associated with acquired long QT syn- drome (LQTS) and torsades de pointes (TdP). Despite this impressive number of reports, the awareness of this subject is still limited among medical professionals and it is virtually absent among the general public, even if some of the adverse reactions have been observed during treatment with agents marketed "over the counter."File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
